Successful eradication of acquired factor-VIII-inhibitor using single low-dose rituximab

Research output: Contribution to journalLetterContributedpeer-review

Contributors

  • Martin Wermke - , Department of Internal Medicine I, University Hospital Carl Gustav Carus Dresden (Author)
  • Malte Von Bonin - , Department of Internal Medicine I, University Hospital Carl Gustav Carus Dresden (Author)
  • Siegmund Gehrisch - , University Hospital Carl Gustav Carus Dresden, Institute for Clinical Chemistry and Laboratory Medicine (Author)
  • Gabriele Siegert - , University Hospital Carl Gustav Carus Dresden, Institute for Clinical Chemistry and Laboratory Medicine (Author)
  • Gerhard Ehninger - , University Hospital Carl Gustav Carus Dresden, Department of internal Medicine I (Author)
  • Uwe Platzbecker - , University Hospital Carl Gustav Carus Dresden, Department of internal Medicine I (Author)

Details

Original languageEnglish
Pages (from-to)521-522
Number of pages2
JournalHaematologica
Volume95
Issue number3
Publication statusPublished - Mar 2010
Peer-reviewedYes

External IDs

PubMed 19903680

Keywords

ASJC Scopus subject areas

Keywords

  • Cyclophosphamide, Hemophilia A, Partial-thromboplastin-time (aPTT)